Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments

By Gillham R.   Baker G.   Thompson P.   Birbeck K.   McGuire A.   Tomlinson L.   Eckersley L.   Silveira C.   Brown S.  

Epilepsy Research, Vol. 24, Iss. 1, 1996-05 ,pp. : 47-55

Elsevier

Access to resources Recommend Favorite

Parent-completed scales for measuring seizure severity and severity of side-effects of antiepileptic drugs in childhood epilepsy: development and psychometric analysis

By Carpay H.A.   Arts W.F.M.   Vermeulen J.   Stroink H.   Brouwer O.F.   Peters A.C.B.   van Donselaar C.A.   Aldenkamp A.P.  

Epilepsy Research, Vol. 24, Iss. 3, 1996-07 ,pp. : 173-181

Elsevier

Access to resources Recommend Favorite

Antiepileptic drug treatment in the developmentally disabled: treatment considerations with the newer antiepileptic drugs

By Rutecki P.A.   Gidal B.E.  

Epilepsy & Behavior, Vol. 3, Iss. 4, 2002-12 ,pp. : 24-31

Academic Press

Access to resources Recommend Favorite

The convergent and divergent validity of the Matson Evaluation of Drug Side-effects (MEDS) and the Dyskinesia Identification System: Condensed User Scale (DISCUS)

By Matson Johnny   Fodstad Jill   Rivet Tessa  

Journal of Intellectual & Developmental Disability, Vol. 33, Iss. 4, 2008-12 ,pp. : 337-344

Informa Healthcare

Access to resources Recommend Favorite

Antiepileptic drug treatment before and after selective amygdalohippocampectomy

By Wieser H.-G.   Hane A.  

Epilepsy Research, Vol. 55, Iss. 3, 2003-08 ,pp. : 211-223

Elsevier

Access to resources Recommend Favorite